Assisted Reproduction Labware Market Size, Share, and Industry Analysis, By Product (Instruments {Microscopes, Incubators, Centrifuges, Cell Counters, Bioreactor, Others}, and Consumables {Culture Dishes, Plates, Syringes, Pipettes, Beakers, Others}), By Type (Disposable and Reusable), By Technique (In Vitro Fertilization-Embryo Transfer (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), and Frozen Embryo Transfer (FET)), By End User (Hospitals, Fertility Clinics, and Others), and Regional Forecast, 2024-2032

Assisted reproduction labware consists of the specialized tools and equipment and the consumables that are used in the laboratories to facilitate assisted reproductive technologies. This includes products such as culture dishes, pipettes, incubators, and other instruments that are essential for various procedures such as in vitro fertilization, embryo culture, sperm analysis, and others. These labware items are designed to create and maintain optimal conditions for the handling and development of reproductive cells, ensuring precision and sterility throughout the various assisted reproductive technologies (ART) techniques.

Furthermore, the increasing infertility rates due to several factors, such as advancing age, lifestyle changes, and several health-related conditions such as obesity, diabetes, and other reproductive disorders are driving the demand for assisted reproduction techniques such as IVF procedures as an increasing number of individuals delay parenthood, age-related fertility declines. In addition, lifestyle changes, including stress, diet, and environmental exposures, further contribute to the decline in fertility rates. Therefore, these procedures offer a solution for those struggling to conceive naturally.

• For instance, in March 2024, according to the data published by the U.S. Department of Health and Human Services, 2.3% of all infants born in the U.S., totaling approximately 86,146 infants, were conceived through IVF in 2021. Moreover, in 2018, in the U.S., over 69.0% of the 120,000 individuals of reproductive age who were diagnosed with cancer required fertility preservation procedures.

Thus, the aforementioned factors have highlighted the significant need for reproductive options for cancer patients, who often face potential infertility due to their treatments. These preservation methods, such as egg and sperm freezing, provide possibilities for the patient undergoing cancer therapies that may impair their reproductive capabilities. The growing preference of individuals shifting toward IVF procedures will lead to the increasing demand for labware products to perform laboratory testing, which will further contribute to the market growth.

The COVID-19 pandemic hampered the market due to the disruptions in fertility treatments and assisted reproduction services due to the reallocation of healthcare resources to combat the COVID-19 pandemic. Several fertility clinics were temporarily closed and significantly reduced their operations, leading to a sharp decline in the number of assisted reproduction procedures performed.

Segmentation

KEY INSIGHTS

The report covers the following key insights:

• Total Number of IVF Procedures, by Key Countries/Regions, 2022/2023


• Infertility Ratio by Key Countries/Regions, 2022/2023


• Overview: Technological Advancements in Assisted Reproduction Labware


• Key Industry Developments (Mergers, Acquisitions, and Partnerships)


• Impact of COVID-19 on the Market

Analysis by Product

By product, the market is segmented into instruments and consumables. The consumables segment dominated the market in 2023, owing to the increasing demand for consumables globally to perform in vitro procedures, intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), and others, which often requires syringes, needles, pipettes, and cultural dishes and plates. Moreover, market players' growing investments in research and development activities have also increased the demand for laboratory supplies. In addition, the growing demand for single-use items essential for ART procedures is further contributing to the segmental growth. Consumables, such as culture media, Petri dishes, and pipette tips, are critical for maintaining sterility and precision in every assisted reproduction cycle.

The instruments segment is projected to witness strong growth prospects in the upcoming years owing to the constant advancements in the products by the market players. This includes innovations such as the integration of software to the microscope, which offers enhanced images. For instance, in February 2024, Alife Health partnered with Ovation Fertility ("Ovation") to streamline laboratory operations with the potential future benefit of enhancing the embryo selection process by the integration of the Embryo Assist software in the microscopes. Thus, constant advancements in this field are further contributing to segmental growth.

Regional Analysis

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to account for a significant global assisted reproductive labware market share. The dominance of the region is primarily due to the advanced healthcare infrastructure that offers innovative healthcare services to patients. Moreover, the growing cases of infertility in the region are also contributing to the region’s market growth. According to the data published by the National Center for Health Statistics in April 2024, the fertility rate amongst the U.S. population dropped by 3.0% from 2022, which represented a historic low. The country has witnessed a decline as compared to the prior year. Thus, the declining cases of fertility are increasing the demand for IVF procedures, further driving the region’s market growth.

Asia Pacific is projected to witness the fastest growth rate in the coming years owing to increasing rates of infertility due to lifestyle changes and environmental factors that are driving the need for better treatment options, further contributing to the market growth. There is a greater awareness and social acceptance of ART procedures, supported by several government initiatives and healthcare policies, further contributing to the region’s growth.

Key Players Covered

The report includes the profiles of key players, such as CooperSurgical Fertility Solutions., GYNEMED GmbH & Co. KG, Merck KGaA, LABOTECT GMBH, ASTEC CO., Ltd., and Corning Incorporated.

Key Industry Developments

• In November 2023, CooperCompanies acquired Cook Medical to strengthen the medical devices portfolio and strengthen the company’s position in the global fertility and women’s health company.


• In December 2021, CooperSurgical Fertility Solutions acquired Generate Life Sciences, a provider of donor eggs and sperm for fertility treatments. The acquisition aims to offer advanced and innovative products to fertility clinics and OB/GYNs to improve treatment offerings.


• In July 2018, Merck KGaA launched two new technologies for enhanced efficiency in the fertility labs. This technology will serve the needs of the customers and will become the better treatment partners for all assisted reproductive treatment (ART) clinics.